Showing 8141-8150 of 18166 results for "".
How Do We Manage Medications in Elderly Populations?
https://reachmd.com/programs/advances-in-long-term-care-medicine/how-do-we-manage-medications-in-elderly-populations/4052/What risks does polypharmacy pose for elderly patients, and how should physicians manage medications in the population of their patients over age 65? Dr. Matthew Wayne, assistant professor of medicine at University Hospitals Case Medical Center in Cleveland, discusses the typical symptoms that mightUltra-Portable Ultrasound in the Critical Care Unit
https://reachmd.com/programs/advances-in-medical-imaging/ultra-portable-ultrasound-in-the-critical-care-unit/3632/So small, it is called the ‘pocket ultrasound,' Dr. Eyal Herzog, director of the cardiac care unit at St. Luke's-Roosevelt Hospital Center in New York, discusses with host Dr. Jason Birnholz the results of his research on the handheld portable ultrasound unit in the cardiac care department. Dr. HerzHow You Can Take Part in Disaster Prep and Response
https://reachmd.com/programs/focus-on-disaster-medicine-and-preparedness/how-you-can-take-part-in-disaster-prep-and-response/3576/There are many avenues for participation by healthcare professionals in disaster preparedness and larger-scale emergency response, but in a sense, many of us are unsure exactly where our areas of expertise would allow us to make a contribution in preparation for, and in response to, a disaster. Shou- The Role of Moderate Weight Loss in Reversing Type 2 Diabetes: Latest Insights and Implicationshttps://reachmd.com/news/the-role-of-moderate-weight-loss-in-reversing-type-2-diabetes-latest-insights-and-implications/2471356/Emerging research highlights the potential of moderate weight loss and lifestyle interventions to reverse type 2 diabetes by improving insulin sensitivity and reducing intrahepatic lipid content. Understanding the Mechanism of Reversal
- Bacteria Triggers Type-1 Diabeteshttps://reachmd.com/news/bacteria-triggers-type-1-diabetes/2468279/Bacteria triggers type-1 diabetes 18 September 2024 Bacterial infections could be the trigger for type-1 diabetes, finds new research by Cardiff University.For the first time, scientists have found that pro
- Innovative Transplant Approach: Preclinical Study on Type 1 Diabetes Treatmenthttps://reachmd.com/news/transplant-preclinical-type-1-diabetes-treatment/2484514/Stanford Medicine researchers have shown that a combined hematopoietic and islet transplant fully prevented or reversed autoimmune Type 1 diabetes in mice, eliminating the need for exogenous ins
- Molecular Insights into Type 2 Diabetes Post-Gestational Diabeteshttps://reachmd.com/news/molecular-insights-into-type-2-diabetes-post-gestational-diabetes/2470920/What's New A new study from the University of Pittsburgh identifies three distinct molecular drivers in type 2 diabetes development in women who had gestational diabetes, suggesting potential pathways for precision medicine applications. Significance
- Insulin Resistance and Type 2 Diabetes Prevention in Youthhttps://reachmd.com/news/insulin-resistance-and-type-2-diabetes-prevention-in-youth/2474568/Recent research highlights the pivotal role of insulin resistance mechanisms in youths with obesity, emphasizing the potential of early lifestyle and pharmacological interventions in preventing type 2 diabetes. Key
- For Type II Diabetes Prevention, Tap into AIhttps://reachmd.com/news/for-type-ii-diabetes-prevention-tap-into-ai/2457362/For Type II Diabetes Prevention, Tap Into AIA model uses artificial intelligence to create better outcomes and save costs for prediabetic patientsBased on the research of Maytal Saar-Tsechansky
- Empagliflozin's Role in Reducing Retinopathy Progression in Type 2 Diabetes: Insights and Implicationshttps://reachmd.com/news/empagliflozins-role-in-reducing-retinopathy-progression-in-type-2-diabetes-insights-and-implications/2471050/What's New A recent study highlights the potential of empagliflozin in mitigating the progression of diabetic retinopathy among patients with type 2 diabetes. Significance These findings are crucial for healthcare providers managing type 2 diabetes,